Total Payments
$12,407
2024 Payments
$2,450
Companies
36
Transactions
467
Medicare Patients
35,063
Medicare Billing
$4.3M
Payment Breakdown by Category
Food & Beverage$12,392 (99.9%)
Education$15.27 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,392 | 466 | 99.9% |
| Education | $15.27 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,785 | 110 | $0 (2024) |
| Lilly USA, LLC | $1,091 | 42 | $0 (2024) |
| GENZYME CORPORATION | $1,070 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,021 | 58 | $0 (2024) |
| Allergan, Inc. | $696.75 | 28 | $0 (2022) |
| PruGen, Inc. Pharmaceuticals | $634.09 | 12 | $0 (2020) |
| Janssen Biotech, Inc. | $580.39 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $560.34 | 18 | $0 (2024) |
| PFIZER INC. | $506.11 | 14 | $0 (2024) |
| UCB, Inc. | $498.35 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,450 | 80 | ABBVIE INC. ($811.26) |
| 2023 | $2,211 | 69 | ABBVIE INC. ($567.37) |
| 2022 | $1,984 | 76 | ABBVIE INC. ($594.97) |
| 2021 | $1,317 | 49 | AbbVie Inc. ($236.33) |
| 2020 | $822.94 | 35 | PruGen, Inc. Pharmaceuticals ($177.87) |
| 2019 | $1,645 | 70 | PruGen, Inc. Pharmaceuticals ($365.22) |
| 2018 | $1,037 | 55 | AbbVie, Inc. ($195.38) |
| 2017 | $941.26 | 33 | Celgene Corporation ($181.40) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.56 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $63.24 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.17 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.67 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $122.34 | General |
| Category: WOUND CARE | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| Category: Immunology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.62 | General |
| Category: Immunology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.32 | General |
| Category: Immunology | ||||||
| 10/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.48 | General |
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $39.40 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 10,004 | 24,006 | $3.3M | $1.5M |
| 2022 | 52 | 9,034 | 18,749 | $2.4M | $1.0M |
| 2021 | 47 | 8,771 | 18,632 | $2.3M | $1.0M |
| 2020 | 47 | 7,254 | 13,348 | $1.8M | $744,831 |
Total Patients
35,063
Total Services
74,735
Medicare Billing
$4.3M
Procedure Codes
208
All Medicare Procedures & Services
208 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,329 | 3,970 | $566,021 | $247,151 | 43.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 50 | 960 | $432,438 | $224,814 | 52.0% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 53 | 1,000 | $300,496 | $156,501 | 52.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 1,238 | 1,596 | $298,950 | $131,060 | 43.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 192 | 242 | $266,262 | $117,100 | 44.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,553 | 2,162 | $235,653 | $81,263 | 34.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 90 | 146 | $98,028 | $51,986 | 53.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,320 | 9,041 | $100,444 | $50,461 | 50.2% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 48 | 928 | $64,109 | $33,206 | 51.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 198 | 253 | $69,617 | $33,120 | 47.6% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 47 | 178 | $53,130 | $27,715 | 52.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 141 | 192 | $55,687 | $24,678 | 44.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 329 | 357 | $59,696 | $23,494 | 39.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 224 | 280 | $56,081 | $21,541 | 38.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 74 | 78 | $59,452 | $18,859 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 191 | $38,441 | $16,596 | 43.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 51 | 53 | $36,617 | $16,148 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 191 | 191 | $33,619 | $13,155 | 39.1% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 14 | 14 | $24,108 | $12,847 | 53.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 38 | 40 | $25,895 | $12,224 | 47.2% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 151 | 208 | $34,851 | $11,651 | 33.4% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 96 | 103 | $23,090 | $9,882 | 42.8% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 44 | 125 | $17,948 | $9,561 | 53.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 53 | 60 | $18,356 | $8,321 | 45.3% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 90 | 105 | $23,656 | $8,128 | 34.4% |
About Dr. Carmelo Plateroti, D.O
Dr. Carmelo Plateroti, D.O is a Dermatology healthcare provider based in Templeton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275556029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmelo Plateroti, D.O has received a total of $12,407 in payments from pharmaceutical and medical device companies, with $2,450 received in 2024. These payments were reported across 467 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,392).
As a Medicare-enrolled provider, Plateroti has provided services to 35,063 Medicare beneficiaries, totaling 74,735 services with total Medicare billing of $4.3M. Data is available for 4 years (2020–2023), covering 208 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Templeton, CA
- Active Since 07/25/2006
- Last Updated 07/14/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1275556029
Products in Payments
- DUPIXENT (Biological) $1,268
- SKYRIZI (Biological) $1,244
- TALTZ (Drug) $836.67
- COSENTYX (Biological) $822.80
- Cimzia (Drug) $453.53
- Humira (Biological) $398.30
- BOTOX (Biological) $352.36
- Otezla (Drug) $349.57
- RINVOQ (Biological) $324.14
- BOTOX COSMETIC (Biological) $287.79
- REMICADE (Biological) $274.25
- OPZELURA (Drug) $272.33
- Sotyktu (Drug) $250.13
- TREMFYA (Drug) $245.40
- EUCRISA (Drug) $243.01
- HUMIRA (Biological) $181.28
- Erivedge (Biological) $174.68
- Ilumya (Biological) $162.45
- ILUMYA (Biological) $140.71
- CIBINQO (Drug) $139.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.